Facteurs inhibant le chimiotactisme au cours des maladies immunoprolifératives: antagonisme in vivo de l'isoprinosine = Inhibiting factors of chemotactism during immunoproliferative syndroms: in vivo antagonism by isoprinosineAZZARA, A; MARGELLI, M; PETRINI, M et al.Médecine et hygiène. 1984, Vol 42, Num 1947, issn 0025-6749, 136Article

Purification and characteristics of the streptococcal chemotactic factor inactivatorWEXLER, D. E; CLEARY, P. P.Infection and immunity. 1985, Vol 50, Num 3, pp 757-764, issn 0019-9567Article

A quantitative assay for ciliate chemotaxisLEICK, V; HELLE, J.Analytical biochemistry. 1983, Vol 135, Num 2, pp 466-469, issn 0003-2697Article

Analysis of the bimodal chemiluminescence pattern stimulated in human neutrophils by chemotactic factorsBENDER, J. G; VAN EPPS, D. E.Infection and immunity. 1983, Vol 41, Num 3, pp 1062-1070, issn 0019-9567Article

INHIBITOR OF ¹²⁵I-CHEMOTACTIC PEPTIDE UPTAKE BY PROTEASE INHIBITORSNIEDEL J; FROTHINGHAM R; CUATRECASAS P et al.1980; BIOCHEM. BIOPHYS. RES. COMMUNIC.; USA; DA. 1980; VOL. 94; NO 2; PP. 667-673; BIBL. 17 REF.Article

BIOLOGICAL ASPECTS OF LEUKOTACTIC FACTORSWARD PA.1976; J. ALLERGY CLIN. IMMUNOL.; U.S.A.; DA. 1976; VOL. 58; NO 1 PART. 2; PP. 224-228; BIBL. 16 REF.Article

TWO DISTINCT CHEMOTACTIC FACTOR INACTIVATORS IN HUMAN SERUMTILL G; WARD PA.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 114; NO 2 PART. 2; PP. 843-847; BIBL. 8REF.Article

LEUCOCYTE CHEMOTACTIC FACTOR GENERATED BY TRYPTIC DIGESTION OF HUMAN IGMAOKI T; SHIMIZU A; YAMAMURA Y et al.1976; IMMUNOCHEMISTRY; G.B.; DA. 1976; VOL. 13; NO 5; PP. 461-467; BIBL. 28 REF.Article

CHARACTERIZATION OF CHEMOTACTIC ACTIVITY PRODUCED IN VIVO BY A CELL-MEDIATED IMMUNE REACTION IN THE GUINEA PIGPOSTLETHWAITE AE; SNYDERMAN R.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 114; NO 1 PART. 2; PP. 274-278; BIBL. 22 REF.Article

THE ISOLATION AND PARTIAL CHARACTERIZATION OF NEUTROPHIL CHEMOTACTIC FACTORS FROM ESCHERICHIA COLISCHIFFMANN E; SHOWELL HV; CORCORAN BA et al.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 114; NO 6; PP. 1831-1837; BIBL. 26 REF.Article

THE ROLE OF AN ADHERENT CELL IN THE PRODUCTION OF MONOCYTE CHEMOTACTIC FACTORVOGEL JE; PAHWA SG; SMITHWICK EM et al.1981; IMMUNOL. LETT.; ISSN 0165-2478; NLD; DA. 1981; VOL. 3; NO 5; PP. 273-276; BIBL. 19 REF.Article

EOSINOPHIL CHEMOTACTIC FACTOR (ECF). II. RELEASE FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES DURING PHAGOCYTOSISKONIG W; CZARNETZKI BM; LICHTENSTEIN LM et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 1; PP. 235-241; BIBL. 30 REF.Article

Characterization of the regulation of complement-derived chemotactic factors in blunt traumaMADERAZO, E. G; MOORE, M; WORONICK, C. L et al.The Journal of infectious diseases. 1988, Vol 157, Num 2, pp 364-367, issn 0022-1899Article

Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophilsSTENSON, W. F; MEHTA, J; SPILBERG, I et al.Biochemical pharmacology. 1984, Vol 33, Num 3, pp 407-412, issn 0006-2952Article

Effect of tunicamycin C₂ on the induction of crystal induced chemotactic factor in human neutrophilsBHATT, A. K; SPILBERG, I.Collection sécurité. 1988, Vol 24, Num 3-4, pp 303-312, issn 0538-4818Article

Effect of membrane fluidizers on the number and affinity of chemotactic factor receptors on human polymorphonuclear leukocytesTOMONAGA, A; HIROTA, M; SNYDERMAN, R et al.Microbiology and immunology. 1983, Vol 27, Num 11, pp 961-972, issn 0385-5600Article

Defective chemotactic factor-induced monocyte complement receptor enhancement in lung cancerCARROLL, M; LUKACS, K; HODSON, M et al.Clinical and experimental immunology (Print). 1983, Vol 54, Num 3, pp 785-792, issn 0009-9104Article

Chemotactic factorsHAEGER, E. B; WASSERMAN, S. I.Immunology and allergy clinics of North America. 1990, Vol 10, Num 2, pp 355-361, issn 0889-8561, 7 p.Article

CHEMOATTRACTANT-RECEPTOR INTERACTIONS IN LEUKOCYTESPIKE MC; SNYDERMAN R.1982; ADV. INFLAMM. RES.; USA; DA. 1982; VOL. 4; PP. 109-130; BIBL. 41 REF.Article

ISOLATION AND CHARACTERIZATION OF AN ACIDIC CHEMOTACTIC FACTOR FROM COMPLEMENT-ACTIVATED HUMAN SERUMBEEBE DP; WARD PA; SPITZNAGEL JK et al.1980; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1980; VOL. 15; NO 1; PP. 88-105; BIBL. 21 REF.Article

LYMPHOKINE PRODUCTION BY C3B-STIMULATED B CELLS.SANDBERG AL; WAHL SM; MERGENHAGEN SE et al.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 115; NO 1; PP. 139-144; BIBL. 29 REF.Article

PHYSICOCHEMICAL CHARACTERIZATION OF CHEMOTACTIC LYMPHOKINES PRODUCED BY HUMAN T AND B LYMPHOCYTES.ALTMAN LC; CHASSY B; MACKLER BF et al.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 115; NO 1; PP. 18-21; BIBL. 13 REF.Article

A UNIQUE COMPLEMENT DERIVED CHEMOTACTIC FACTOR FOR TUMOR CELLS.ROMUALDEZ AG JR; WARD PA.1975; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1975; VOL. 72; NO 10; PP. 4128-4132; BIBL. 24 REF.Article

CHEMOTACTIC FACTOR RECEPTORS ON LEUKOCYTES - SCRATCHING THE SURFACEGOLDSTEIN IM.1981; J. LAB. CLIN. MED.; ISSN 0022-2143; USA; DA. 1981; VOL. 97; NO 5; PP. 599-601; BIBL. 18 REF.Article

DEMONSTRATION OF CALCIUM-DEPENDENT CHEMOTACTIC FACTOR ACTIVATABLE ESTERASE ACTIVITY IN HUMAN NEUTROPHILS: RELATIONSHIP WITH CHEMOTAXIS AND CHEMOTACTIC DEACTIVATIONMEHTA J; MANDELL B; KLEYMAN T et al.1981; INFLAMMATION; ISSN 0360-3997; USA; DA. 1981; VOL. 5; NO 2; PP. 89-101; BIBL. 20 REF.Article